Lecanemab in Early Alzheimer's Disease
N Engl J Med
.
2023 Apr 27;388(17):1630-1631.
doi: 10.1056/NEJMc2301380.
Authors
Nunzio Pomara
1
,
Bruno P Imbimbo
2
Affiliations
1
Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY nunzio.pomara@nki.rfmh.org.
2
Chiesi Farmaceutici, Parma, Italy.
PMID:
37099353
DOI:
10.1056/NEJMc2301380
No abstract available
Publication types
Letter
Comment
MeSH terms
Alzheimer Disease*
Humans
Positron-Emission Tomography
Substances
lecanemab